Literature DB >> 27349452

The delta opioid receptor tool box.

Ana Vicente-Sanchez1, Laura Segura1, Amynah A Pradhan2.   

Abstract

In recent years, the delta opioid receptor has attracted increasing interest as a target for the treatment of chronic pain and emotional disorders. Due to their therapeutic potential, numerous tools have been developed to study the delta opioid receptor from both a molecular and a functional perspective. This review summarizes the most commonly available tools, with an emphasis on their use and limitations. Here, we describe (1) the cell-based assays used to study the delta opioid receptor. (2) The features of several delta opioid receptor ligands, including peptide and non-peptide drugs. (3) The existing approaches to detect delta opioid receptors in fixed tissue, and debates that surround these techniques. (4) Behavioral assays used to study the in vivo effects of delta opioid receptor agonists; including locomotor stimulation and convulsions that are induced by some ligands, but not others. (5) The characterization of genetically modified mice used specifically to study the delta opioid receptor. Overall, this review aims to provide a guideline for the use of these tools with the final goal of increasing our understanding of delta opioid receptor physiology.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor; cell lines; mutant mice; pain

Mesh:

Substances:

Year:  2016        PMID: 27349452      PMCID: PMC5083241          DOI: 10.1016/j.neuroscience.2016.06.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  206 in total

1.  Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization.

Authors:  Z J Cheng; G H Fan; J Zhao; Z Zhang; Y L Wu; L Z Jiang; Y Zhu; G Pei; L Ma
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

Review 2.  The pharmacological profile of delta opioid receptor ligands, (+) and (-) TAN-67 on pain modulation.

Authors:  H Nagase; Y Yajima; H Fujii; K Kawamura; M Narita; J Kamei; T Suzuki
Journal:  Life Sci       Date:  2001-04-06       Impact factor: 5.037

3.  Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.

Authors:  Hanieh Bagheri Tudashki; Derek N Robertson; Peter W Schiller; Graciela Pineyro
Journal:  Mol Pharmacol       Date:  2013-10-30       Impact factor: 4.436

4.  Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.

Authors:  S S Negus; M B Gatch; N K Mello; X Zhang; K Rice
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

5.  Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells.

Authors:  L Ma; Z J Cheng; G H Fan; Y C Cai; L Z Jiang; G Pei
Journal:  FEBS Lett       Date:  1997-02-10       Impact factor: 4.124

6.  Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers.

Authors:  S A Williams; T J Abbruscato; V J Hruby; T P Davis
Journal:  J Neurochem       Date:  1996-03       Impact factor: 5.372

7.  Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells.

Authors:  D Platika; M H Boulos; L Baizer; M C Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 8.  The anxiodepressive comorbidity in chronic pain.

Authors:  Ipek Yalcin; Michel Barrot
Journal:  Curr Opin Anaesthesiol       Date:  2014-10       Impact factor: 2.706

9.  Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.

Authors:  S C Roerig; H H Loh; P Y Law
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

10.  Influence of the time in culture on cellular and neuronal properties of neuroblastoma x glioma hybrid cells. With an appendix, mathematical description of the kinetics of the loss in cell volume.

Authors:  R Heumann; G Valet; D Maison; J Kemper; G Reiser; B Hamprecht
Journal:  J Cell Sci       Date:  1977       Impact factor: 5.285

View more
  10 in total

Review 1.  Emerging Treatment Targets for Migraine and Other Headaches.

Authors:  Zachariah Bertels; Amynah Amir Ali Pradhan
Journal:  Headache       Date:  2019-07       Impact factor: 5.887

2.  Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.

Authors:  Ana Vicente-Sanchez; Isaac J Dripps; Alycia F Tipton; Heba Akbari; Areeb Akbari; Emily M Jutkiewicz; Amynah A Pradhan
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

3.  Delta opioid receptor agonists are effective for multiple types of headache disorders.

Authors:  Laura S Moye; Alycia F Tipton; Isaac Dripps; Zoie Sheets; Aimee Crombie; Jonathan D Violin; Amynah A Pradhan
Journal:  Neuropharmacology       Date:  2018-12-14       Impact factor: 5.250

4.  Inflammation-associated changes in DOR expression and function in the mouse colon.

Authors:  Jesse J DiCello; Ayame Saito; Pradeep Rajasekhar; Emily M Eriksson; Rachel M McQuade; Cameron J Nowell; Benjamin W Sebastian; Jakub Fichna; Nicholas A Veldhuis; Meritxell Canals; Nigel W Bunnett; Simona E Carbone; Daniel P Poole
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

Review 5.  Novel Pharmacological Nonopioid Therapies in Chronic Pain.

Authors:  Alan David Kaye; Elyse M Cornett; Brendon Hart; Shilpadevi Patil; Andrew Pham; Matthew Spalitta; Kenneth F Mancuso
Journal:  Curr Pain Headache Rep       Date:  2018-04-03

Review 6.  From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception.

Authors:  Meridith T Robins; Mary M Heinricher; Andrey E Ryabinin
Journal:  Alcohol Alcohol       Date:  2019-12-01       Impact factor: 2.826

7.  Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.

Authors:  Laura S Moye; Kendra Siegersma; Isaac Dripps; Wiktor Witkowski; Elizaveta Mangutov; Dong Wang; Grégory Scherrer; Amynah A Pradhan
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

Review 8.  Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions.

Authors:  Francesca Felicia Caputi; Laura Rullo; Serena Stamatakos; Sanzio Candeletti; Patrizia Romualdi
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

9.  Assessing the Structural and Pharmacological Similarity of Newly Identified Drugs of Abuse to Controlled Substances Using Public Health Assessment via Structural Evaluation.

Authors:  Christopher R Ellis; Rebecca Racz; Naomi L Kruhlak; Marlene T Kim; Edward G Hawkins; David G Strauss; Lidiya Stavitskaya
Journal:  Clin Pharmacol Ther       Date:  2019-04-08       Impact factor: 6.875

10.  Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain.

Authors:  Catherine M Cahill; Sarah V Holdridge; Shiwei Steve Liu; Lihua Xue; Claire Magnussen; Edmund Ong; Patrick Grenier; Anne Sutherland; Mary C Olmstead
Journal:  J Neurosci Res       Date:  2020-07-05       Impact factor: 4.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.